Daily Dose - Mar 8th, 2024
 
 
Daily Dose | View online
 
March 8, 2024
Welcome to Editors' (re)View, where Pharma Manufacturing editors handpick notable industry happenings that deserve some extra consideration. See what you may have missed this week in pharma.
The company is contemplating a potential market withdrawal, pending discussions with regulatory bodies.
The agency will convene an unexpected advisory panel meeting to dig deeper into the safety and efficacy of donanemab.
Sponsored
Learn how to identify common pitfalls in planning and scheduling processes, understand how to build a case for investing in maintenance planning, and discover strategies to optimize the availability of spare parts inventory for maintenance.